121 related articles for article (PubMed ID: 19031738)
21. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
Wang F; Qi LX; Su Y; Yan QH; Teng Y
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.
Santos J; Cerveira N; Bizarro S; Ribeiro FR; Correia C; Torres L; Lisboa S; Vieira J; Mariz JM; Norton L; Snijder S; Mellink CH; Buijs A; Shih LY; Strehl S; Micci F; Heim S; Teixeira MR
Leuk Res; 2010 May; 34(5):615-21. PubMed ID: 19748670
[TBL] [Abstract][Full Text] [Related]
24. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
25. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
[TBL] [Abstract][Full Text] [Related]
26. AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.
Park JW; Cho H; Oh H; Kim JY; Seo SB
Mol Cells; 2018 May; 41(5):444-453. PubMed ID: 29477140
[TBL] [Abstract][Full Text] [Related]
27. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
28. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
30. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract][Full Text] [Related]
31. [Mechanism of inhibiting proliferation of human ovarian cancer cells of the line HO-8910 by dexamethasone: the role of RhoB signaling pathway].
Chen YX; Li ZB; Diao F; Wang Y; Lu J
Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1400-4. PubMed ID: 16796923
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
Sengupta A; Banerjee D; Chandra S; Banerjee S
J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
[TBL] [Abstract][Full Text] [Related]
33. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
34. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
35. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes.
Fleischmann KK; Pagel P; Schmid I; Roscher AA
Mol Cancer; 2014 Feb; 13():27. PubMed ID: 24517546
[TBL] [Abstract][Full Text] [Related]
36. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
37. [The effects of JARID1B siRNA on proliferation and apoptosis in HL-60 cell].
Ma XD; Han HD; Huang YQ; Zou Y
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):392-6. PubMed ID: 22781799
[TBL] [Abstract][Full Text] [Related]
38. [Acute monoblastic leukemia with MLL/AF9 rearrangement which developed 18 months after myeloid sarcoma onset].
Sato Y; Nakazawa A; Kurosawa H; Fukushima K; Okuya M; Hagisawa S; Sugita K; Arisaka O
Rinsho Ketsueki; 2013 Dec; 54(12):2167-70. PubMed ID: 24452147
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
40. Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.
Zhang LS; Kang X; Lu J; Zhang Y; Wu X; Wu G; Zheng J; Tuladhar R; Shi H; Wang Q; Morlock L; Yao H; Huang LJ; Maire P; Kim J; Williams N; Xu J; Chen C; Zhang CC; Lum L
EBioMedicine; 2019 Jan; 39():145-158. PubMed ID: 30528456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
